Raymond James Financial’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.63M Sell
72,728
-28,743
-28% -$750K ﹤0.01% 3652
2026
Q1
$2.78M Sell
101,471
-19,039
-16% -$676K ﹤0.01% 3084
2025
Q4
$5.01M Sell
120,510
-22,192
-16% -$900K ﹤0.01% 2511
2025
Q3
$6.59M Buy
142,702
+13,450
+10% +$717K ﹤0.01% 2249
2025
Q2
$6.83M Buy
129,252
+2,347
+2% +$124K ﹤0.01% 2158
2025
Q1
$7.06M Buy
126,905
+17,072
+16% +$818K ﹤0.01% 2070
2024
Q4
$4.75M Buy
+109,833
New +$4.88M ﹤0.01% 2362

Other funds holding CNXC

Raymond James Financial's CNXC Position: Q2 2026 in Review

Raymond James Financial reduced its Concentrix (CNXC) stake by 28% in Q2 2026, selling an estimated $750K and leaving 72,728 shares worth $1.63M. The position accounts for ﹤0.01% of the portfolio, ranked #3652.

Raymond James Financial first reported a position in CNXC in Q4 2024 and has held it in 7 quarters since. The position peaked at $7.06M in Q1 2025. 272 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Raymond James Financial held 72,728 shares of Concentrix worth $1.63M as of Q2 2026.
  • Raymond James Financial sold 28,743 Concentrix shares in Q2 2026, an estimated $750K.
  • Concentrix made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #3652 holding.
  • Raymond James Financial first reported a position in Concentrix in Q4 2024 and has held it in 7 quarters since.
  • Raymond James Financial's Concentrix position peaked at $7.06M in Q1 2025.
  • 272 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.